8.59
-0.07
(-0.81%)
Bei Börsenschluss: January 31 at 5:35:52 PM GMT+1
Insider-Käufe (letzte 6 Monate)
| Aktien | Transaktionen | |
|---|---|---|
| Käufe | 0 | 0 |
| Verkauf | -- | 0 |
| Gekaufte Nettoaktien (verkauft) | 0 | 0 |
| Insideraktien mit Beteiligung (gesamt) | 7.06M | -- |
| % Gekaufte Nettoaktien (verkauft) | -- | -- |
Institutionelle Käufe (netto) der letzten Quartale
| Aktien | |
|---|---|
| Gekaufte Nettoaktien (verkauft) | -- |
| % Schwankung in institutioneller Aktienbeteiligung | -- |
Gemeldete Insider-Transaktionen – Letzte zwei Jahre
| Insider | Transaktion | Typ | Wert | Datum |
|---|---|---|---|---|
| JACOBS JOHN C Chief Executive Officer | -- | Direct | -- | Jan 23, 2025 |
| KELLY JAMES PATRICK Chief Financial Officer | -- | Direct | -- | Dec 31, 2024 |
| YOUNG JAMES FRANCIS Director | Sale at price 8.00 - 8.48 per share. | Direct | 82,208 | Dec 31, 2024 |
| KING RACHEL K Director | Sale at price 9.02 per share. | Direct | 37,435 | Dec 13, 2024 |
| CASEY MARK J Officer | -- | Direct | -- | Dec 11, 2024 |
| RODGERS RICHARD J. Director | -- | Direct | -- | Oct 29, 2024 |
| TRIZZINO JOHN J Officer | -- | Direct | -- | Aug 19, 2024 |
| KELLY JAMES PATRICK Chief Financial Officer | Conversion of Exercise of derivative security at price 12.96 per share. | Direct | 30,676 | Aug 16, 2024 |
| YOUNG JAMES FRANCIS Director | Sale at price 14.09 per share. | Direct | 105,675 | Jun 21, 2024 |
| YOUNG JAMES FRANCIS Director | Sale at price 13.62 - 14.28 per share. | Direct | 102,881 | Jun 18, 2024 |
| DUBOVSKY FILIP Officer | Conversion of Exercise of derivative security at price 6.09 - 6.97 per share. | Direct | 85,911 | Jun 17, 2024 |
| DUBOVSKY FILIP Officer | Sale at price 14.46 - 14.54 per share. | Direct | 201,164 | Jun 17, 2024 |
| KING RACHEL K Director | -- | Direct | -- | Jun 12, 2024 |
| MOTT DAVID M Director | -- | Direct | -- | Jun 12, 2024 |
| RODGERS RICHARD J. Director | -- | Direct | -- | Jun 12, 2024 |
| ALTON GREGG H Director | -- | Direct | -- | Jun 12, 2024 |
| YOUNG JAMES FRANCIS Director | -- | Direct | -- | Jun 12, 2024 |
| MCGLYNN MARGARET G Director | -- | Direct | -- | Jun 12, 2024 |
| DOUGLAS RICHARD H Director | -- | Direct | -- | Jun 12, 2024 |
| DUBOVSKY FILIP Officer | Conversion of Exercise of derivative security at price 6.97 per share. | Direct | 136,974 | May 14, 2024 |
| DUBOVSKY FILIP Officer | Sale at price 13.90 per share. | Direct | 657,637 | May 14, 2024 |
| TRIZZINO JOHN J President | -- | Direct | -- | Mar 8, 2024 |
| KELLY JAMES PATRICK Chief Financial Officer | -- | Direct | -- | Mar 8, 2024 |
| DUBOVSKY FILIP Officer | -- | Direct | -- | Mar 8, 2024 |
| TRIZZINO JOHN J Officer | -- | Direct | -- | Mar 7, 2024 |
| KELLY JAMES PATRICK Chief Financial Officer | -- | Direct | -- | Mar 7, 2024 |
| DUBOVSKY FILIP Officer | -- | Direct | -- | Mar 7, 2024 |
| O'HARA ELAINE Officer | Conversion of Exercise of derivative security at price 5.39 per share. | Direct | 105,644 | Mar 1, 2024 |
| JACOBS JOHN C Chief Executive Officer | -- | Direct | -- | Jan 23, 2024 |
| TRIZZINO JOHN J Chairman of the Board | -- | Direct | -- | Dec 14, 2023 |
| DUBOVSKY FILIP Officer | -- | Direct | -- | Dec 14, 2023 |
| HERRMANN JOHN A III Officer | -- | Direct | -- | Dec 14, 2023 |
| DUBOVSKY FILIP Officer | -- | Direct | -- | Nov 3, 2023 |
| RODGERS RICHARD J. Director | -- | Direct | -- | Oct 27, 2023 |
| DUBOVSKY FILIP Officer | -- | Direct | -- | Sep 15, 2023 |
| TRIZZINO JOHN J Chairman of the Board | -- | Direct | -- | Aug 18, 2023 |
| KELLY JAMES PATRICK Chief Financial Officer | -- | Direct | -- | Aug 16, 2023 |
| TRIZZINO JOHN J Chairman of the Board | -- | Direct | -- | Jun 23, 2023 |
| HERRMANN JOHN A III Officer | -- | Direct | -- | Jun 23, 2023 |
| DUBOVSKY FILIP Officer | -- | Direct | -- | Jun 16, 2023 |
| KING RACHEL K Director | -- | Direct | -- | Jun 9, 2023 |
| MOTT DAVID M Director | -- | Direct | -- | Jun 9, 2023 |
| ALTON GREGG H Director | -- | Direct | -- | Jun 9, 2023 |
| YOUNG JAMES FRANCIS Director | -- | Direct | -- | Jun 9, 2023 |
| MCGLYNN MARGARET G Director | -- | Direct | -- | Jun 9, 2023 |
| DOUGLAS RICHARD H Director | -- | Direct | -- | Jun 9, 2023 |
| GLENN GREGORY M Officer | Purchase at price 6.50 - 7.48 per share. | Direct | 43,042 | Mar 10, 2023 |
| TRIZZINO JOHN J Officer | -- | Direct | -- | Mar 10, 2023 |
| KELLY JAMES PATRICK Chief Financial Officer | Conversion of Exercise of derivative security at price 6.52 per share. | Direct | 30,051 | Mar 10, 2023 |
| GLENN GREGORY M Officer | -- | Direct | -- | Mar 10, 2023 |
Ähnliche Ticker
BIO3.DE Biotest Aktiengesellschaft
28.00
+2.19%
BIO.DE Biotest Aktiengesellschaft
41.40
0.00%
9VC.DE Atai Life Sciences N.V.
1.4955
+2.89%
T5O0.DE bioXXmed AG
0.9600
+10.85%
88Q.DE 4basebio PLC
14.00
+0.72%
PSH.DE Sernova Corp.
0.1447
+0.56%
7V0.DE Darwin AG
26.00
+0.78%
VX1.DE Vertex Pharmaceuticals Incorporated
445.25
+5.17%
AYJ.DE Valneva SE
2.7600
+11.29%
HPHA.DE Heidelberg Pharma AG
2.3900
-2.45%